See how efforts are bringing blood-based Alzheimer's diagnostics to Latin America and the Caribbean. Highlights implementation, partnerships, and practical barriers.
Key Takeaways
- Become increasingly sophisticated at detecting the biological signs of Alzheimer’s disease
- Breakthrough is only a breakthrough if it reaches people
- More people are reaching the ages at which cognitive decline becomes increasingly common